(USO) Compass oncology — Vancouver, Washington

(USO) Compass oncology is a clinical research site located in Vancouver, Washington, United States 98684.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

(USO) Compass oncology has participated in 1 clinical trials.

Therapeutic areas: Relapsed/Refractory Multiple Myeloma (RRMM), Metastatic Colorectal Cancer (mCRC), Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Sponsors: Karyopharm Therapeutics Inc.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for (USO) Compass oncology?

(USO) Compass oncology has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has (USO) Compass oncology conducted?

(USO) Compass oncology has 1 clinical trials on record. Their work covers Relapsed/Refractory Multiple Myeloma (RRMM), Metastatic Colorectal Cancer (mCRC), Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Is (USO) Compass oncology accredited by Crixeo Health?

(USO) Compass oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about (USO) Compass oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.